To extend this window, the GAS6–Axl axis—which remains persistently upregulated after PS exposure, can be assayed, and plasma Axl levels or single‐cell RNA sequencing (scRNA‐seq) can be used to track tumor burden and treatment response [136]. The gene discussed is AXL; the disease is neoplasm.